Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Genes May Predict Elderly Blindness Risk

Two mutations boost the odds for severe macular degeneration, study finds

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Alzheimer's Disease
Cataracts
Central Serous Retinopathy
Conjunctivitis
More...

Related Healthscout Videos
 border=
Howard: The Helping Hand for Stroke Survivors
Helping Blind Kids See
Fixing Torn Hearts
Medicine's Next Big Thing? Growing Hearts
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Erectile Dysfunction
LASIK
What is a Heart Attack?
More...

Related Drug Information
 border=
Actonel
Coumadin
Detrol LA
Ditropan XL
More...

Related News Articles
 border=
Most Sports-Related Eye Injuries Are Preventable
Health Tip: Talking to a Person With Alzheimer's Disease
Talk Therapy Proves Effective for Terminal Cancer Patients
Metabolic Syndrome Triggered by Overeating, Not Obesity
More...

TUESDAY, April 24 (HealthDay News) -- Two genes could determine an older person's vulnerability to an advanced form of age-related macular degeneration (AMD), researchers report.

People who smoked or were overweight faced an even greater risk for the potentially blinding eye condition, the study found.

Text Continues Below



"The two genetic variants are related and predict to a certain extent which individuals who have earlier-intermediate forms of macular degeneration progress to the advanced form and visual loss," explained the study's lead author, Dr. Johanna M. Seddon, director of the Ophthalmic, Epidemiology and Genetics Service in the department of ophthalmology at Tufts-New England Medical Center and New England Eye Center.

"Genetic variants are part of the way we can differentiate who gets worse, coupled with environmental factors like a high body mass index and smoking," said Seddon, whose team published its results in the April 25 issue of the Journal of the American Medical Association.

The findings have implications for the prevention of AMD, one expert said.

"They've actually identified specific genes and specific abnormalities in specific genes that prove that macular degeneration has a strong genetic component," said Dr. Robert Cykiert, clinical associate professor of ophthalmology at New York University School of Medicine in New York City. "What this says is if you have someone in your immediate family such as parents or siblings with AMD, then you need to see an ophthalmologist and be carefully followed, because there are things that can be done to prevent progression."

Down the line, there may even be a blood test to detect these genes, further brightening the picture for prevention and early treatment, Cykiert said.

But it's too early to recommend widespread screening, the authors stated.

"Some individuals who progress do not have these genetic variants or have never smoked," Seddon said. "We need to refine this predictive measure, add more genetic variants and maybe even more environmental factors."

Page:  1 | 2 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 4/24/2007

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





New Features

New ADHD Site!

SOURCES: Johanna M. Seddon, M.D., Sc.M., director, Ophthalmic, Epidemiology and Genetics Service, department of ophthalmology, Tufts-New England Medical Center and New England Eye Center, Boston; Robert Cykiert, M.D., clinical associate professor, ophthalmology, New York University School of Medicine, New York City; April 25, 2007, Journal of the American Medical Association


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map